LXRX Share Price

Open 14.41 Change Price %
High 14.56 1 Day -0.24 -1.67
Low 14.02 1 Week -0.13 -0.91
Close 14.16 1 Month -1.88 -11.72
Volume 740455 1 Year 2.31 19.49
52 Week High 19.62
52 Week Low 11.52
LXRX Important Levels
Resistance 2 14.66
Resistance 1 14.45
Pivot 14.25
Support 1 13.87
Support 2 13.66
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
FTR 1.98 -1.98%
FTR 1.98 -1.98%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
LOCM 0.09 50.00%
SSH 2.31 32.76%
SSH 2.31 32.76%
SSH 2.31 32.76%
LTRE 2.40 31.87%
HPJ 4.90 30.67%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
ORIG 0.23 -68.49%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)

LXRX Technical Analysis 4
As on 28th Mar 2017 LXRX Share Price closed @ 14.16 and we RECOMMEND Sell for LONG-TERM with Stoploss of 15.24 & Strong Sell for SHORT-TERM with Stoploss of 14.88 we also expect STOCK to react on Following IMPORTANT LEVELS.
LXRX Target for March
1st Target up-side 17.48
2nd Target up-side 18.49
3rd Target up-side 19.5
1st Target down-side 14.6
2nd Target down-side 13.59
3rd Target down-side 12.58
LXRX Other Details
Segment EQ
Market Capital 962548544.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.lexpharma.com
LXRX Address
LXRX
8800 Technology Forest Place
The Woodlands, TX 77381
United States
Phone: 281-863-3000
Fax: 281-863-8088
LXRX Latest News
Interactive Technical Analysis Chart Lexicon Pharmaceuticals, Inc. ( LXRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lexicon Pharmaceuticals, Inc.
LXRX Business Profile
Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. It has five drug programs in various stages of clinical development and has advanced small molecule compounds from a number of additional drug programs into various stages of preclinical development and research. Its drug program includes LX4211, LX1032, LX1033, LX2931 and LX7101.